MedRx Co., Ltd (4586.T)

JPY 84.0

(-3.45%)

Operating Expenses Summary of MedRx Co., Ltd

  • MedRx Co., Ltd's latest annual operating expenses in 2023 was 959 Million JPY , down -17.28% from previous year.
  • MedRx Co., Ltd's latest quarterly operating expenses in 2024 Q2 was 179.97 Million JPY , up 2.21% from previous quarter.
  • MedRx Co., Ltd reported a annual operating expenses of 1.15 Billion JPY in annual operating expenses 2022, up 8.28% from previous year.
  • MedRx Co., Ltd reported a annual operating expenses of 1.06 Billion JPY in annual operating expenses 2021, down -14.04% from previous year.
  • MedRx Co., Ltd reported a quarterly operating expenses of 176.07 Million JPY for 2024 Q1, down -30.01% from previous quarter.
  • MedRx Co., Ltd reported a quarterly operating expenses of 251.57 Million JPY for 2023 Q4, up 17.36% from previous quarter.

Annual Operating Expenses Chart of MedRx Co., Ltd (2023 - 2019)

Historical Annual Operating Expenses of MedRx Co., Ltd (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 959 Million JPY -17.28%
2022 1.15 Billion JPY 8.28%
2021 1.06 Billion JPY -14.04%
2020 1.24 Billion JPY -30.74%
2019 1.79 Billion JPY 0.0%

Peer Operating Expenses Comparison of MedRx Co., Ltd

Name Operating Expenses Operating Expenses Difference
Pharma Foods International Co., Ltd. 43.63 Billion JPY 97.802%
Takeda Pharmaceutical Company Limited 2618.18 Billion JPY 99.963%
Sumitomo Pharma Co., Ltd. 542.17 Billion JPY 99.823%
Shionogi & Co., Ltd. 197.62 Billion JPY 99.515%
Wakamoto Pharmaceutical Co.,Ltd. 3.73 Billion JPY 74.333%
Nippon Shinyaku Co., Ltd. 65.63 Billion JPY 98.539%
Kaken Pharmaceutical Co., Ltd. 29.02 Billion JPY 96.696%
Eisai Co., Ltd. 533.01 Billion JPY 99.82%
Morishita Jintan Co., Ltd. 5.28 Billion JPY 81.844%
Hisamitsu Pharmaceutical Co., Inc. 65.8 Billion JPY 98.543%
Mochida Pharmaceutical Co., Ltd. 46.26 Billion JPY 97.927%
Fuso Pharmaceutical Industries,Ltd. 11.55 Billion JPY 91.699%
Nippon Chemiphar Co., Ltd. 8.23 Billion JPY 88.35%
Tsumura & Co. 48.8 Billion JPY 98.035%
Kissei Pharmaceutical Co., Ltd. 33.32 Billion JPY 97.122%
Torii Pharmaceutical Co., Ltd. 19.53 Billion JPY 95.091%
Towa Pharmaceutical Co., Ltd. 63.73 Billion JPY 98.495%
Fuji Pharma Co., Ltd. 12.65 Billion JPY 92.423%
Zeria Pharmaceutical Co., Ltd. 40.46 Billion JPY 97.63%
KYORIN Holdings, Inc. 45.39 Billion JPY 97.887%
Taiko Pharmaceutical Co.,Ltd. 4.15 Billion JPY 76.93%
Daito Pharmaceutical Co.,Ltd. 5.94 Billion JPY 83.869%
SymBio Pharmaceuticals Limited 5.22 Billion JPY 81.638%
Mizuho Medy Co.,Ltd. 2.87 Billion JPY 66.629%
Solasia Pharma K.K. 1.47 Billion JPY 35.027%
Modalis Therapeutics Corporation 2.37 Billion JPY 59.547%
ASKA Pharmaceutical Holdings Co.,Ltd. 24.16 Billion JPY 96.031%
Sawai Group Holdings Co., Ltd. 35.43 Billion JPY 97.293%
Cyfuse Biomedical K.K. 735.18 Million JPY -30.444%
Toho Holdings Co., Ltd. 99.81 Billion JPY 99.039%
Koa Shoji Holdings Co.,Ltd. 2.25 Billion JPY 57.515%